Pyridinyl morpholine compound, preparation method therefor, and application thereof
US12410136B2 · kind B2 · utility
0Cited by
4References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 28, 2021 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Oct 26, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in the present invention are a pyridinyl morpholine compound, a preparation method therefor, and an application thereof. The present invention provides a pyridinyl morpholine compound as represented by formula I, a pharmaceutically acceptable salt thereof or a hydrate of the pharmaceutically acceptable salt thereof. The compound can be used as an antagonist for one or more of D2, D3 or 5-HT2A, and is used for preparing a drug for treating schizophrenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.